A Clinical Trial to Find Out How Effective Saptanga Guggulu Is for Treating Nadi-Vrana

A Randomized Controlled Clinical Trial To Study The Effect Of Saptanga Guggulu In Nadi-Vrana With Special Reference To Pilonidal Sinus. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072265

Enrollment

Registered

2024-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L050- Pilonidal cyst and sinus with abscess

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Pilonidal sinus of the sacrococcygeal region Age between 19 to 29 years of both gender No evidence of malignancy

Exclusion criteria

Exclusion criteria: Associated with malignancy Patients with known cases of DM, HTN, TB, cardiac disorder, etc.

Design outcomes

Primary

Measure	Time frame
Reduction of Sign and Symptoms of Nadi Vrana after intervention of Saptanga GugguluTimepoint: 55 Days	—

Secondary

Measure	Time frame
Where the trial group stands in comparison with control groupTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Sagar Rajendra Dashpute

SMBT Ayurved College And Hospital

adkpc74@gmail.com9689339928

Outcome results